These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14845363)

  • 1. [A case of leprosy of a lepromatous and tuberculoid form with neural lesions; evolution under the effect of sulfone therapy].
    ALAJOUANINE T; CASTAIGNE P; BLATRIX C
    Rev Neurol (Paris); 1951 Jan; 84(1):65-7. PubMed ID: 14845363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evolution of a case of tuberculoid leprosy toward an atypical form and later toward a lepromatous form].
    MARIANO J
    Arq Min Leprol; 1950 Jan; 10(1):21-6. PubMed ID: 15420073
    [No Abstract]   [Full Text] [Related]  

  • 3. The sulfone treatment of tuberculoid leprosy.
    LOWE J
    Int J Lepr; 1950; 18(4:1):457-68. PubMed ID: 14803132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of the therapeutic action of sulfone derivatives in lepromatous leprosy].
    de SOUZA PR; de LIMA MS
    Rev Bras Leprol; 1950 Jun; 18(2):59-68. PubMed ID: 14781471
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cutaneous determination of Hansen's disease in pure neural leprosy patients under the influence of sulfone treatment].
    LITALIEN F; HARTER P; TRINH THI KIM MONG DON ; NGUYEN THI DANH
    Bull Soc Pathol Exot Filiales; 1960; 53():943-9. PubMed ID: 13762697
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of lepromatous leprosy with 4:4'-diaminodiphenyl sulfone in oil; findings in 100 cases treated for one year.
    MOLESWORTH BD; NARAYANASWAMI PS
    Int J Lepr; 1949; 17(3):197-210, 5 pl. PubMed ID: 15399691
    [No Abstract]   [Full Text] [Related]  

  • 7. [The 4:4 '-diamino diphenyl sulfone in the treatment of lepromatous leprosy].
    DUARTE LG; DE MELLO PH
    Rev Bras Leprol; 1953 Sep; 21(3):207-20. PubMed ID: 13167563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bacteriological action of 1-(p-[N,N-dimethylaminolphenyl)-3-(p-n-butoxyphenyl)-2-thiorea on leprosy of the lepromatous type and on leprosy of the sulfone-resistant dimorphic type].
    MONTESTRUC E; BENOIST J
    Bull Soc Pathol Exot Filiales; 1960; 53():13-6. PubMed ID: 13848669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diamino-diphenyl-sulfone, dihydrostreptomycin and p-aminosalicylic acid in the treatment of lepromatous leprosy].
    GONZALEZ OCHOA A; MARTINEZ BAEZ M; LAVALLE AGUILAR P; CASTRO ESTRADA S
    Bol Oficina Sanit Panam; 1952 Oct; 33(4):306-29. PubMed ID: 12977879
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of epidermal cell proliferation in skin lesions in lepromatous leprosy is greater than in indeterminate and tuberculoid leprosy lesions.
    Palermo MH; Vugman I; Fleury RN; Zucoloto S
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):37-43. PubMed ID: 8627111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation studies in lepromatous leprosy; third series: nicotinamide, and BCG vaccination as supplements to diaminodiphenyl sulfone (DDS).
    DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV
    Int J Lepr; 1958; 26(3):219-35. PubMed ID: 13640759
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapses after sulfone therapy in leprosy of the lepromatous type.
    RODRIGUEZ JN
    Int J Lepr; 1959; 26(4):305-12. PubMed ID: 13672660
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulfone therapy in lepromatous children at Colônia Santa Isabel, Brazil].
    ORSINI O; TAVARES I
    Arq Min Leprol; 1951 Jan; 11(1):16-33. PubMed ID: 14869252
    [No Abstract]   [Full Text] [Related]  

  • 16. Initial dosage of diaminodiphenyl sulfone in the treatment of tuberculoid leprosy.
    LEWIS RA; KYI-KYI K; EDWARDS R
    Int J Lepr; 1957; 25(4, Part 1):370-4. PubMed ID: 13562944
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severe relapse of a lepromatous leper treated for six years by the sulfone J-51].
    CHAUSSINAND R; BOURCART N
    Presse Med (1893); 1959 Aug; 67():1534. PubMed ID: 13809492
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacteriological action of Ciba-1906 (1-(p-dimethylaminophenyl)-3-(p-butoxyphenyl)-2-thiourea) in lepers of the lepromatous and sulfone-resistant dimorphous type].
    MONTESTRUC E; BENOIST J
    Arch Inst Pasteur Martinique; 1960; 13():17-9. PubMed ID: 13772179
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin D in massive doses as an adjuvant to the sulfones in the treatment of tuberculoid leprosy.
    HERRERA G
    Int J Lepr; 1949; 17(1-2):35-42. PubMed ID: 18143438
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of lepromatous leprosy with combined sulfone-streptomycin-hydrazide of isonicotinic acid].
    ORSINI O
    Arq Min Leprol; 1957 Jul; 17(3):291-4. PubMed ID: 13522478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.